Santhera Pharmaceuticals Appoints Catherine Isted As CFO, Andrew Smith To Step Down
Feb 10, 2025•6 months ago
Position
Chief Financial Officer
Company
Santhera Pharmaceuticals
PrattelnBiopharmaTherapeuticsPharmaceuticalBiotechnologyHealth CareDescription
Catherine Isted, an experienced healthcare CFO with over 25 years in life sciences, has been appointed as CFO effective February 24, 2025. Current CFO Andrew Smith will step down after five years with Santhera and will support an orderly transition. The appointment of Catherine Isted brings proven financial leadership to support the next growth phase of Santhera Pharmaceuticals.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months